Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan D Struthers

Showing results (21-30 of 165) with videos related to

Pageof 17
Sort By:
Expert Review of Cardiovascular Therapy|March 25, 2004
The role of aldosterone in heart failure and the clinical benefits of aldosterone blockadeAdelle Dawson, Justine I Davies, Allan D Struthers
Cardiovascular Journal of Africa|November 13, 2009
Heart rate variability as an indicator of left ventricular systolic dysfunctionAbdullah Shehab, Asim A Elnour, Allan D Struthers
Current Heart Failure Reports|November 16, 2013
Novel blockers of the renin-angiotensin-aldosterone system in chronic heart failureArchyut Valluri, Allan D Struthers, Chim C Lang
Age and Ageing|June 26, 2004
Age is not a significant risk factor for failed trial of beta-blocker therapy in older patients with chronic heart failureMiles D Witham, Neil D Gillespie, Allan D Struthers
Heart Failure Reviews|June 11, 2005
Autonomic effects of spironolactone and MR blockers in heart failureJustine I Davies, Miles D Witham, Allan D Struthers
Journal of Hypertension|July 10, 2009
Effect of vitamin D on blood pressure: a systematic review and meta-analysisMiles D Witham, M Adnan Nadir, Allan D Struthers
Journal of Hypertension|January 16, 2002
The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism?Pitt O Lim, Allan D Struthers, Thomas M MacDonald
British Journal of Clinical Pharmacology|November 4, 2004
Tolerability of spironolactone in patients with chronic heart failure -- a cautionary messageMiles D Witham, Neil D Gillespie, Allan D Struthers
Gerontology|July 20, 2006
Sarcopenia--a potential target for Angiotensin-converting enzyme inhibition?Deepa Sumukadas, Allan D Struthers, Marion E T McMurdo
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|August 6, 2004
Tonic levels of angiotensin II reduce tonic levels of vascular nitric oxide even in salt-replete manJustein S N Sim, Colin Farquharson, Allan D Struthers
Pageof 17

Showing results (21-30 of 165) with videos related to

Sort By:
Pageof 17
Expert Review of Cardiovascular Therapy|March 25, 2004
The role of aldosterone in heart failure and the clinical benefits of aldosterone blockadeAdelle Dawson, Justine I Davies, Allan D Struthers
Cardiovascular Journal of Africa|November 13, 2009
Heart rate variability as an indicator of left ventricular systolic dysfunctionAbdullah Shehab, Asim A Elnour, Allan D Struthers
Current Heart Failure Reports|November 16, 2013
Novel blockers of the renin-angiotensin-aldosterone system in chronic heart failureArchyut Valluri, Allan D Struthers, Chim C Lang
Age and Ageing|June 26, 2004
Age is not a significant risk factor for failed trial of beta-blocker therapy in older patients with chronic heart failureMiles D Witham, Neil D Gillespie, Allan D Struthers
Heart Failure Reviews|June 11, 2005
Autonomic effects of spironolactone and MR blockers in heart failureJustine I Davies, Miles D Witham, Allan D Struthers
Journal of Hypertension|July 10, 2009
Effect of vitamin D on blood pressure: a systematic review and meta-analysisMiles D Witham, M Adnan Nadir, Allan D Struthers
Journal of Hypertension|January 16, 2002
The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism?Pitt O Lim, Allan D Struthers, Thomas M MacDonald
British Journal of Clinical Pharmacology|November 4, 2004
Tolerability of spironolactone in patients with chronic heart failure -- a cautionary messageMiles D Witham, Neil D Gillespie, Allan D Struthers
Gerontology|July 20, 2006
Sarcopenia--a potential target for Angiotensin-converting enzyme inhibition?Deepa Sumukadas, Allan D Struthers, Marion E T McMurdo
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|August 6, 2004
Tonic levels of angiotensin II reduce tonic levels of vascular nitric oxide even in salt-replete manJustein S N Sim, Colin Farquharson, Allan D Struthers
Pageof 17